These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30593137)

  • 1. Population genetic difference of pharmacogenomic VIP gene variants in the Lisu population from Yunnan Province.
    Zhang C; Jiang X; Chen W; Li Q; Yun F; Yang X; Dai R; Cheng Y
    Medicine (Baltimore); 2018 Dec; 97(52):e13674. PubMed ID: 30593137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of pharmacogenomic VIP variants in the Lisu population of southwestern China: A cohort study.
    Li B; Wang L; Lei L; Zhang M; Niu F; Chen P; Jin T
    Medicine (Baltimore); 2018 Sep; 97(38):e12231. PubMed ID: 30235667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation of pharmacogenomic VIP variants in Zhuang nationality of southern China.
    Liu Y; Li H; Cao K; Liu J; Sun Y; Wu J; Xiong Z; Niu F; Li J; Jin T
    Pharmacogenomics J; 2021 Feb; 21(1):60-68. PubMed ID: 32699276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of very important pharmacogene variants in the Chinese Lisu population.
    Lu H; Zhang Z; Wang Y; Wang L; Yuan D; He Y; Jin T
    Per Med; 2023 May; 20(3):239-249. PubMed ID: 37427690
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic polymorphisms in very important pharmacogenomic variants in the Zhuang ethnic group of Southwestern China: A cohort study in the Zhuang population.
    Li J; Guo C; Yan M; Niu F; Chen P; Li B; Jin T
    Medicine (Baltimore); 2018 Apr; 97(17):e0559. PubMed ID: 29703042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of pharmacogenomic VIP variants in the Yi population from China.
    Yan M; Li D; Zhao G; Li J; Niu F; Li B; Chen P; Jin T
    Gene; 2018 Mar; 648():54-62. PubMed ID: 29337087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China.
    Zhou W; Guo J; Li Y; Ma X; Yang S; Wei J; Zhang H; Zhang S; Jin T
    Funct Integr Genomics; 2023 Mar; 23(2):85. PubMed ID: 36930384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China.
    Li D; Peng L; Xing S; He C; Jin T
    BMC Genom Data; 2021 Nov; 22(1):51. PubMed ID: 34798807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of pharmacogenomic VIP variants in the Lahu population from Yunnan Province.
    Dou X; Yang S; Zhang W; Meng W; Zhao W; Hao J; Hu X; Guo L; Jin T
    Gene; 2022 Nov; 844():146825. PubMed ID: 35995116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations.
    Ma X; Li Y; Zang X; Guo J; Zhou W; Han J; Liang J; Wan P; Yang H; Jin T
    Cancer Chemother Pharmacol; 2024 May; 93(5):481-496. PubMed ID: 38300251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province.
    Cheng Y; Dai R; Chen W; Li Q; Zhang C; Yang T
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1231. PubMed ID: 32347657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China.
    Chen W; Ding H; Cheng Y; Li Q; Dai R; Yang X; Zhang C
    Mol Genet Genomic Med; 2019 Sep; 7(9):e884. PubMed ID: 31361092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of pharmacogenomic VIP variants in the Kyrgyz population from northwest China.
    Yunus Z; Liu L; Wang H; Zhang L; Li X; Geng T; Kang L; Jin T; Chen C
    Gene; 2013 Oct; 529(1):88-93. PubMed ID: 23954225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms study of pharmacogenomic VIP variants in Han ethnic of China's Shaanxi province.
    Jin T; Zhao R; Shi X; He N; He X; Ouyang Y; Wang H; Wang B; Kang L; Yuan D
    Environ Toxicol Pharmacol; 2016 Sep; 46():27-35. PubMed ID: 27414743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation of pharmacogenomic VIP variants in the Chinese Li population: an updated research.
    Yang S; Dou X; Wang Z; Zhang W; Ding K; Meng W; Li H; Liu J; Liu Y; Jin T
    Mol Genet Genomics; 2022 Mar; 297(2):407-417. PubMed ID: 35146537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Polymorphisms Analysis of Pharmacogenomic VIP Variants in Miao Ethnic Group of Southwest China.
    Jin T; Aikemu A; Zhang M; Geng T; Feng T; Kang L; Luo ML
    Med Sci Monit; 2015 Dec; 21():3769-76. PubMed ID: 26632549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of pharmacogenomic VIP variants in Li nationality of southern China.
    Ding Y; He P; He N; Li Q; Sun J; Yao J; Yi S; Xu H; Wu D; Wang X; Jin T
    Environ Toxicol Pharmacol; 2016 Mar; 42():237-42. PubMed ID: 26901752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China.
    Zhang C; Guo W; Cheng Y; Li Q; Yang X; Dai R; Zhu L; Chen W
    Mol Genet Genomic Med; 2019 May; 7(5):e574. PubMed ID: 30955239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of pharmacogenomic very important pharmacogenomic variants:
    Meng W; Zhang W; Yang S; Dou X; Liu Y; Li H; Liu J; Jin T; Li B
    Per Med; 2022 Sep; 19(5):403-410. PubMed ID: 35801384
    [No Abstract]   [Full Text] [Related]  

  • 20. Very important pharmacogenes polymorphism landscape and potential clinical relevance in the Chinese Mongolian.
    Guo L; Zhang W; Meng W; Zhao W; Hao J; Hu X; Jin T
    Gene; 2023 Jan; 850():146960. PubMed ID: 36220448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.